AAAAAA
Results: 1-25/39
Authors:
Van Aken, H
Bode, C
Darius, H
Diehm, C
Encke, M
Gulba, DC
Haas, S
Hacke, W
Puhl, W
Quante, M
Riess, H
Scharf, R
Schellong, S
Schror, K
Schulte, KL
Tebbe, U
Citation: H. Van Aken et al., Anticoagulation: The present and future, CL APPL T-H, 7(3), 2001, pp. 195-204
Authors:
Hermann, A
Rauch, BH
Braun, M
Schror, K
Weber, AA
Citation: A. Hermann et al., Platelet CD40 ligand (CD40L) - subcellular localization, regulation of expression, and inhibition by clopidogrel, PLATELETS, 12(2), 2001, pp. 74-82
Authors:
Schror, K
Citation: K. Schror, Pathophysiology of platelet activation and pharmacology of GPIIb/IIIa antagonists, HERZ, 26, 2001, pp. 30-35
Authors:
Weber, AA
Hermann, A
Rauch, BH
Schror, K
Citation: Aa. Weber et al., Molecular identity of platelet CD40 ligand (CD40L), THROMB HAEM, 86(2), 2001, pp. 718-718
Authors:
Weber, AA
Braun, M
Hohlfeld, T
Schwippert, B
Tschope, D
Schror, K
Citation: Aa. Weber et al., Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers, BR J CL PH, 52(3), 2001, pp. 333-336
Authors:
Bretschneider, E
Schror, K
Citation: E. Bretschneider et K. Schror, Cellular effects of factor Xa on vascular smooth muscle cells - Inhibitionby heparins?, SEM THROMB, 27(5), 2001, pp. 489-493
Authors:
Osinski, MT
Rauch, BH
Schror, K
Citation: Mt. Osinski et al., Antimitogenic actions of organic nitrates are potentiated by sildenafil and mediated via activation of protein kinase A, MOLEC PHARM, 59(5), 2001, pp. 1044-1050
Authors:
Zimmermann, N
Kienzle, P
Weber, AA
Winter, J
Gams, E
Schror, K
Hohlfeld, T
Citation: N. Zimmermann et al., Aspirin resistance after coronary artery bypass grafting, J THOR SURG, 121(5), 2001, pp. 982-984
Authors:
Bretschneider, E
Kaufmann, R
Braun, M
Nowak, G
Glusa, E
Schror, K
Citation: E. Bretschneider et al., Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells, BR J PHARM, 132(7), 2001, pp. 1441-1446
Authors:
Weber, AA
Schror, K
Citation: Aa. Weber et K. Schror, Differential inhibition of adenosine diphosphate-versus thrombin receptor-activating peptide-stimulated platelet fibrinogen binding by abciximab due to different glycoprotein IIb/IIIa activation kinetics, BLOOD, 98(5), 2001, pp. 1619-1621
Authors:
Klein, BC
Bach, D
Rehfeld, I
Kirchhoff, E
Hohlfeld, T
Schror, K
Scharf, R
Grabensee, B
Citation: Bc. Klein et al., Influence of mycophenolic acid and FK-506 on human platelet activation in vitro, KIDNEY BL P, 23(2), 2000, pp. 119-124
Authors:
Weber, AA
Liesener, S
Schanz, A
Hohlfeld, T
Schror, K
Citation: Aa. Weber et al., Habitual smoking causes an abnormality in platelet thromboxane A(2) metabolism and results in an altered susceptibility to aspirin effects, PLATELETS, 11(3), 2000, pp. 177-182
Authors:
Meyer-Kirchrath, J
Schror, K
Citation: J. Meyer-kirchrath et K. Schror, Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract, CURR MED CH, 7(11), 2000, pp. 1121-1129
Authors:
Klockenbusch, W
Goecke, TW
Krussel, JS
Tutschek, BA
Crombach, G
Schror, K
Citation: W. Klockenbusch et al., Prostacyclin deficiency and reduced fetoplacental blood flow in pregnancy-induced hypertension and preeclampsia, GYNECOL OBS, 50(2), 2000, pp. 103-107
Authors:
Hohlfeld, T
Schutz, A
Vogel, YC
Stalleicken, D
Braun, M
Schror, K
Citation: T. Hohlfeld et al., Hemodynamic and antiischemic effects of intravenous pentaerithrityltetranitrate, HERZ, 25(7), 2000, pp. 694-702
Authors:
Bretschneider, E
Braun, M
Fischer, A
Wittpoth, M
Glusa, E
Schror, K
Citation: E. Bretschneider et al., Factor Xa acts as a PDGF-independent mitogen in human vascular smooth muscle cells, THROMB HAEM, 84(3), 2000, pp. 499-505
Authors:
Dschietzig, T
Alexiou, K
Laule, M
Becker, R
Schror, K
Baumann, G
Brunner, F
Stangl, K
Citation: T. Dschietzig et al., Stimulation of pulmonary big endothelin-1 and endothelin-1 by antithrombinIII: A rationale for combined application of antithrombin III and endothelin antagonists in sepsis-related acute respiratory distress syndrome?, CRIT CARE M, 28(7), 2000, pp. 2445-2449
Authors:
Weber, AA
Koppen, O
Schror, K
Citation: Aa. Weber et al., Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism, THROMB RES, 98(5), 2000, pp. 461-466
Authors:
Weber, AA
Liesener, S
Hohlfeld, T
Schror, K
Citation: Aa. Weber et al., 40 mg of aspirin are not sufficient to inhibit platelet function under conditions of limited compliance, THROMB RES, 97(5), 2000, pp. 365-367
Authors:
Hohlfeld, T
Meyer-Kirchrath, J
Vogel, YC
Schror, K
Citation: T. Hohlfeld et al., Reduction of infarct size by selective stimulation of prostaglandin EP3 receptors in the reperfused ischemic pig heart, J MOL CEL C, 32(2), 2000, pp. 285-296
Authors:
Nilius, SM
Hasse, A
Kuger, P
Schror, K
Meyer-Kirchrath, J
Citation: Sm. Nilius et al., Agonist-induced long-term desensitization of the human prostacyclin receptor, FEBS LETTER, 484(3), 2000, pp. 211-216
Authors:
Rauch, BH
Weber, AA
Braun, M
Zimmermann, N
Schror, K
Citation: Bh. Rauch et al., PDGF-induced Akt phosphorylation does not activate NF-kappa B in human vascular smooth muscle cells and fibroblasts, FEBS LETTER, 481(1), 2000, pp. 3-7
Authors:
Osinski, MT
Weber, AA
Schror, K
Citation: Mt. Osinski et al., Complex actions of protein kinase A inhibitors on mitogenesis of bovine coronary artery smooth muscle cells, EUR J PHARM, 395(3), 2000, pp. 173-176
Authors:
Weber, AA
Yildirim, H
Schror, K
Citation: Aa. Weber et al., Cyclooxygenase-independent inhibition of smooth muscle cell mitogenesis byibuprofen, EUR J PHARM, 389(1), 2000, pp. 67-69
Authors:
Osinski, MT
Schror, K
Citation: Mt. Osinski et K. Schror, Inhibition of platelet-derived growth factor-induced mitogenesis by phosphodiesterase 3 inhibitors - Role of protein kinase A in vascular smooth muscle cell mitogenesis, BIOCH PHARM, 60(3), 2000, pp. 381-387